VituVingiSana wrote:Well, there is a simple solution...
Last price was 5.60 before the suspension.
I will not put a hard timeline [see my loss to @sparkly even though KK has outperformed KenGen since 1st Jan 2018 but I had said 31st Dec 2017] but what are we looking at here?
So @xxxxx [niko ndani na wewe] what's your timeline that ARM will be back on the board and back to 5.60?
 I believe this thing is surprisingly going to end rather quickly. All the interested parties plus regulators are on it to ensure the suspension is lifted as per the announcement.
UBA will achieve its goal of avoiding a huge provision having demonstrated to CBK that recovery measures and timelines have been formally agreed upon.
CDC's hand has now been forced and so they will provide much more clarity on exactly when and how much funding is to be provided to resolve the liabilities particularly. As you know they've been dragging their feet for almost 2 years.
NSE/CBK/ CMA are jointly apprised of the agreed Ts and Cs and life goes on.
The minority shareholders.. especially those who bought at 2.7 smile all the way to the bank albeit with some dilution ..thou not to KQ levels. Keep on riding on the shoulders of CDC.
On lifting the suspension, the only way is UP.
The purpose of the administration action was to push CDC to COMMIT ASAP.